Adaptive Biotechnologies ADPT
NASDAQ ADPT
$24.71 +0.76 (+3.17%)
As of: Oct 20, 2026 · 2:27 PM EDT

Adaptive Biotechnologies (ADPT) Cash from Restructuring (2024 - 2026)

Updated

Analysis

Adaptive Biotechnologies (ADPT) Cash from Restructuring (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 102.21 Bn 98.22 Bn -
2 Natera 58.61 Bn 54.29 Bn 485.19 Mn
3 Labcorp Holdings 26.27 Bn 24.02 Bn 1.11 Bn
4 Quest Diagnostics 26.14 Bn 24.27 Bn 1.03 Bn
5 Tenet Healthcare 22.68 Bn 11.69 Bn -
6 Guardant Health 21.55 Bn 17.62 Bn 219.03 Mn
7 BrightSpring Health Services 12.85 Bn 11.18 Bn 492.75 Mn
8 Fresenius Medical Care AG 12.40 Bn 4.35 Bn 1.52 Bn
9 Tempus AI 12.37 Bn 9.40 Bn 246.50 Mn
10 Adaptive Biotechnologies 3.95 Bn 2.95 Bn 51.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 643,000.00
Dec 31, 2024 87,000.00
Sep 30, 2024 193,000.00
Jun 30, 2024 680,000.00
API Access

Adaptive Biotechnologies Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=ADPT&period=max&api_key=YOUR_API_KEY